Pharming Group Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Pharming Group stock has a consensus rating of "Strong Buy" and an average price target of $34.35. The average 1-year stock price forecast is 166.82% higher than the current stock price, while the lowest is $23.4 (+81.77%) and the highest is $40 (+210.71%).

Price Target: $34.35 (+166.82%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23.4	$34.35	$37	$40
Change	+81.77%	+166.82%	+187.41%	+210.71%

Analyst Ratings

The average analyst rating for Pharming Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $37	Buy	Reiterates	$37	+187.41%	Jun 4, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Buy Maintains $12 → $37	Buy	Maintains	$12 → $37	+187.41%	May 8, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Maintains $41 → $40	Buy	Maintains	$41 → $40	+210.71%	May 8, 2026

Financial Forecast

Revenue This Year

403.53M

from 376.13M

7.28%

from 376.13M

Revenue Next Year

447.80M

from 403.53M

10.97%

from 403.53M

EPS This Year

0.03

from 0.00

669.25%

from 0.00

EPS Next Year

0.04

from 0.03

17.68%

from 0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	198.87M	205.62M	245.32M	297.20M	376.13M	403.53M
Revenue Growth	-6.27%	3.40%	19.30%	21.15%	26.56%	7.28%
Gross Profit	177.73M	188.06M	220.10M	261.80M	330.63M	367.21M
Gross Margin	89.37%	91.46%	89.72%	88.09%	87.90%	91.00%
Operating Income	24.00M	10.37M	-21.75M	-3.59M	32.76M	41.85M
Net Income	16.00M	13.67M	-10.55M	-11.84M	2.85M	43.03M
EPS	-	-	-	-	0.00	0.03
EPS Growth	-	-	-	-	-	669.25%
Forward PE	-	-	-	-	-	418.38
Free Cash Flow	-17.14M	16.23M	8.06M	242.13K	68.65M	38.90M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	412.9M
Avg	403.5M
Low	390.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	9.8%
Avg	7.3%
Low	3.7%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.03
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	669.3%
Low	-